Get the latest on Cellectar Biosciences' Q3 2025 earnings, EMA progress for iopofosine, clinical pipeline updates, and strategic outlook.
Good morning, ladies and gentlemen, and welcome to the Cellectar Biosciences' Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I ...
CARDIAMP CMI Cohort Results -- In the open-label rolling cohort (n=5), patients saw an average 80-second increase in exercise ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.
According to SportsLine's Inside the Lines team, one team on Monday night has much more to lose than the other in Week 11 ...
We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback